{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:18:13Z","timestamp":1788459493798,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11102-026-01736-z","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:59:00Z","timestamp":1785175140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Authors\u2019 reply to the Comment on Osteometabolic complications in patients with secreting pituitary adenomas: Is there an impact of gender?"],"prefix":"10.1007","volume":"29","author":[{"given":"Andrea","family":"Giustina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"di Filippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"1736_CR1","doi-asserted-by":"crossref","unstructured":"Dandinoglu T, Guner A (2026) Comment on: Osteometabolic complications in patients with secretory pituitary adenomas: Is there an impact off gender? Pituitary","DOI":"10.1007\/s11102-026-01731-4"},{"issue":"3","key":"1736_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11102-026-01667-9","volume":"29","author":"L di Filippo","year":"2026","unstructured":"di Filippo L, Acanfora M, Bolamperti S, Terenzi U, Bonomo M, Giustina A (2026) Osteometabolic complications in patients with secreting pituitary adenomas: Is there an impact of gender? Pituitary 29(3):96. https:\/\/doi.org\/10.1007\/s11102-026-01667-9","journal-title":"Pituitary"},{"issue":"19","key":"1736_CR3","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMra2409076","volume":"393","author":"A Giustina","year":"2025","unstructured":"Giustina A, Colao A (2025) Acromegaly N. Engl J Med 393(19):1926\u20131939 https:\/\/doi.org\/10.1056\/NEJMra2409076","journal-title":"Engl J Med"},{"issue":"3","key":"1736_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11102-026-01674-w","volume":"29","author":"L di Filippo","year":"2026","unstructured":"di Filippo L, Frara S, Terenzi U, Menotti S, Mortini P, Giustina A (2026) Vertebral fractures may occur early in the history of Cushing disease associating with male gender and degree of cortisol secretion. Pituitary 29(3):72. https:\/\/doi.org\/10.1007\/s11102-026-01674-w","journal-title":"Pituitary"},{"issue":"4","key":"1736_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11102-011-0293-4","volume":"14","author":"G Mazziotti","year":"2011","unstructured":"Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299\u2013306. https:\/\/doi.org\/10.1007\/s11102-011-0293-4","journal-title":"Pituitary"},{"issue":"15","key":"1736_CR6","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/s0002-9149(99)80721-8","volume":"75","author":"A Giustina","year":"1995","unstructured":"Giustina A, Boni E, Romanelli G, Grassi V, Giustina G (1995) Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol 75(15):1042\u20131047. https:\/\/doi.org\/10.1016\/s0002-9149(99)80721-8","journal-title":"Am J Cardiol"},{"issue":"3","key":"1736_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11102-026-01639-z","volume":"29","author":"A Giustina","year":"2026","unstructured":"Giustina A, di Filippo L, Fleseriu M, Pivonello R, Petersenn S, Wass J, Samson SL, Pereira AM, Luque RM, Biagetti B, Zatelli MC, Ho KKY, Boguszewski CL, van der Lely AJ, Gurnell M, Biermasz N, Schilbach K, Ferone D, Gadelha MR, Ioachimescu AG, Ghigo E, Strasburger CJ, Kadioglu P, Maffei P, Karavitaki N, Marazuela M, Buchfelder M, Chiloiro S, Luger A, Greenman Y, Valassi E, Bernabeu I, Frara S, Chanson P, Brue T, Ayuk J, Casanueva FF, Colao A, Mortini P, Neggers S, Puig-Domingo M, Uygur MM, Melmed S (2026) Consensus on acromegaly complications: an update. Pituitary 29(3):76. https:\/\/doi.org\/10.1007\/s11102-026-01639-z","journal-title":"Pituitary"},{"issue":"4","key":"1736_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11102-024-01397-w","volume":"27","author":"A Giustina","year":"2024","unstructured":"Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2024) Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary 27(4):381\u2013388. https:\/\/doi.org\/10.1007\/s11102-024-01397-w","journal-title":"Pituitary"},{"issue":"4","key":"1736_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.tem.2023.01.006","volume":"34","author":"MM Uygur","year":"2023","unstructured":"Uygur MM, Frara S, di Filippo L, Giustina A (2023) New tools for bone health assessment in secreting pituitary adenomas. Trends Endocrinol Metab 34(4):231\u2013242. https:\/\/doi.org\/10.1016\/j.tem.2023.01.006","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"1736_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s11102-024-01469-x","volume":"27","author":"MM Uygur","year":"2024","unstructured":"Uygur MM, Menotti S, Santoro S, Giustina A (2024) Modern approach to bone comorbidity in prolactinoma. Pituitary 27(6):802\u2013812. https:\/\/doi.org\/10.1007\/s11102-024-01469-x","journal-title":"Pituitary"},{"issue":"6","key":"1736_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s11102-022-01266-4","volume":"25","author":"S Chiloiro","year":"2022","unstructured":"Chiloiro S, Giampietro A, Gagliardi I, Bondanelli M, Veleno M, Ambrosio MR, Zatelli MC, Pontecorvi A, Giustina A, De Marinis L, Bianchi A (2022) Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience. Pituitary 25(6):831\u2013841. https:\/\/doi.org\/10.1007\/s11102-022-01266-4","journal-title":"Pituitary"},{"key":"1736_CR12","doi-asserted-by":"publisher","unstructured":"Chiloiro S, Frara S, Gagliardi I, Bianchi A, Giampietro A, Medici M, Allora A, di Filippo L, Ambrosio MR, Pontecorvi A, Zatelli MC, De Marinis L, Giustina A (2023) Cholecalciferol use is associated with a decreased risk of incident morphometric vertebral fractures in acromegaly. J Clin Endocrinol Metab dgad493. https:\/\/doi.org\/10.1210\/clinem\/dgad493","DOI":"10.1210\/clinem\/dgad493"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01736-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-026-01736-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-026-01736-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:42:05Z","timestamp":1788457325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-026-01736-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1736"],"URL":"https:\/\/doi.org\/10.1007\/s11102-026-01736-z","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.G. has occasionally consulted for Abiogen, Amolyt Pharma, Ipsen, Pfizer, Recordati Rare Diseases and Crinetics. L.D.F. received research grants from Abiogen, and his research activities are partly supported by Glucocorticoid Induced Osteoporosis Skeletal Endocrinology Group (GIOSEG). A.G. is Editor in Chief of Pituitary. L.D.F is Associate Editor of Pituitary.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"134"}}